AG00H60B

945526-43-2 | ISCK03

Chemical structure of ISCK03, CAS 945526-43-2
AG00H60B
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 945526-43-2
Catalog Number AG00H60B(AGN-PC-0L0542)
Chemical Name ISCK03
IUPAC Name 4-tert-butyl-N-(4-imidazol-1-ylphenyl)benzenesulfonamide
InChI InChI=1S/C19H21N3O2S/c1-19(2,3)15-4-10-18(11-5-15)25(23,24)21-16-6-8-17(9-7-16)22-13-12-20-14-22/h4-14,21H,1-3H3
InChI Key XQABBHBFHWHMKF-UHFFFAOYSA-N
MDL Number MFCD12031591
Molecular Formula C19H21N3O2S
Molecular Weight 355.4539
SMILES CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC1=CC=C(C=C1)N1C=NC=C1
UNII 3028H7W568
Synonyms
4-t-butylphenyl-N-(4-imidazol-1-ylphenyl)sulfonamide, ISCK03, ISCK03, 945526-43-2, Stem-Cell Factor/c-Kit Inhibitor, ISCK03, tert-Butylphenyl imidazolylphenyl sulfonamide, UNII-3028H7W568, ISCK-03, 3028H7W568, 4-tert-butyl-N-(4-imidazol-1-ylphenyl)benzenesulfonamide, Whiteplex-IN, ISCK 03, AC1MXMIY, t-Butylphenyl imidazolylphenyl sulfonamide, t-Butylphenyl imidazolylphenyl sulfonamide [INCI], ISCK 03;ISCK-03, SCHEMBL5318665, CTK8F0498, DTXSID70241524, Stem-Cell Factor/c-Kit Inhibitor, HMS3229P07, BCP20053, EX-A1323, MFCD12031591, ZINC35212838, Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(4-(1H-imidazol-1-yl)phenyl)-, CS-6336, ISCK03, >=98% (HPLC), solid, AK687968, HY-101443, RT-015790, (4-t-butylphenyl)-N-(4-imidazole-1-yl phenyl)sulfonamide, [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide, Benzenesulfonamide,4-(1,1-dimethylethyl)-N-[4-(1H-imidazol-1-yl)phenyl], CID3792751, t-Butylphenyl imidazolylphenyl sulfonamide {inci], N-(4-imidazol-1-ylphenyl)-4-tert-butyl-benzenesulfonamide, [4-t-Butylphenyl]-N- sulfonamide,Benzenesulfonamide,4- -N-[4- phenyl]-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited